BCL2L1 and diffuse large B-cell lymphoma: Abnormal activation of the NF-κB signaling pathway and overexpression of downstream antiapoptotic proteins such as Bcl-2, Bcl-xL, and Mcl-1 may be the main causes of drug-resistant ABC-DLBCL [14].